Supernus Pharmaceuticals
SUPN
#4462
Rank
โ‚ฌ1.51 B
Marketcap
27,16ย โ‚ฌ
Share price
0.00%
Change (1 day)
-2.91%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ0.29 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚ฌ0.29 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.31 B-0.87%
2023-12-31โ‚ฌ0.32 B-57.66%
2022-12-31โ‚ฌ0.76 B-1.31%
2021-12-31โ‚ฌ0.77 B24.92%
2020-12-31โ‚ฌ0.61 B22.42%
2019-12-31โ‚ฌ0.50 B9.92%
2018-12-31โ‚ฌ0.45 B250.62%
2017-12-31โ‚ฌ0.13 B16.81%
2016-12-31โ‚ฌ0.11 B21.71%
2015-12-31โ‚ฌ92.02 M16.48%
2014-12-31โ‚ฌ79 M40.72%
2013-12-31โ‚ฌ56.14 M103.91%
2012-12-31โ‚ฌ27.53 M-19.27%
2011-12-31โ‚ฌ34.1 M-50.33%
2010-12-31โ‚ฌ68.66 M14.31%
2009-12-31โ‚ฌ60.06 M0.11%
2008-12-31โ‚ฌ60 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.81 B 176.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.76 B 19,290.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ67.13 B 22,832.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.51 B 9,983.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ95.66 B 32,581.59%๐Ÿ‡บ๐Ÿ‡ธ USA